Drug Discovery AI
Drug Discovery AI17
About
What does Drug Discovery AI do?
Valence Labs is Recursion's AI research engine, focused on predicting, explaining, and discovering new ways to decode biology. It leverages Recursion's platform, data, and computing infrastructure to model cellular responses to perturbations, generate causal explanations for molecular interventions, and discover novel therapeutic hypotheses. Valence Labs serves the drug discovery industry by accelerating and improving therapeutic outcomes.
Where is Drug Discovery AI headquartered?
Drug Discovery AI is headquartered in Boston, United States.
When was Drug Discovery AI founded?
Drug Discovery AI was founded in 2023.
What industry does Drug Discovery AI operate in?
Drug Discovery AI operates in AI Drug Discovery, Biotech, HealthTech, Drug Discovery, Foundation Model, Generative AI.
How many employees does Drug Discovery AI have?
Drug Discovery AI has approximately 35 people on record.
Discover innovative AI therapeutics at fibrotherapeutics.ai, enhancing patient care and advancing health technology.
Zyvorx is a biotechnology company using AI and computational biology to accelerate drug discovery and development.
An entrant is a company tagged AI Drug Discovery whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.